Importantly, genes recently described as drivers in thyroid cancers, such as EIF1AX, IDH1, PTEN, NF1, CHEK2, RB1, MEN1, DICER, SK11, MLL, and CDH4, were not mutated in the 14 negative samples. This evidence concerns the gene CHEK2 and thyroid gland carcinoma.